LPL Financial Portfolio holdings
LPL Financial, founded in 1989 through the merger of Linsco and Private Ledger and headquartered in San Diego, California, is the largest independent broker-dealer in the U.S., supporting over 22,000 financial advisors who manage more than $1.4 trillion in advisory and brokerage assets as of late 2024. Serving independent advisors, banks, and credit unions, LPL provides a robust technology platform, research, and back-office support, enabling advisors to offer personalized wealth management, retirement planning, and investment services to clients without proprietary products. The firm, publicly traded since 2010 under CEO Dan Arnold, has grown through acquisitions like Waddell & Reed’s wealth management business in 2021, emphasizing flexibility and advisor autonomy. With additional offices in Fort Mill, South Carolina, and Boston, LPL Financial remains a leader in empowering advisors amid a shifting financial landscape.
Top Buys
| 1 |
iShares S&P 500 Growth ETF
IVW
|
+$372M |
| 2 |
Apple
AAPL
|
+$254M |
| 3 |
Microsoft
MSFT
|
+$229M |
| 4 |
iShares MSCI EAFE Growth ETF
EFG
|
+$223M |
| 5 |
BlackRock US Equity Factor Rotation ETF
DYNF
|
+$190M |
Top Sells
| 1 |
iShares MSCI EAFE Value ETF
EFV
|
+$121M |
| 2 |
iShares ESG Aware MSCI USA ETF
ESGU
|
+$66.7M |
| 3 |
Vanguard Total Bond Market
BND
|
+$66.6M |
| 4 |
Health Care Select Sector SPDR Fund
XLV
|
+$61.6M |
| 5 |
iShares Global Energy ETF
IXC
|
+$60.3M |
Sector Composition
| 1 | Technology | 8.16% |
| 2 | Financials | 3.17% |
| 3 | Healthcare | 2.8% |
| 4 | Consumer Discretionary | 2.64% |
| 5 | Industrials | 2.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1626
AB InBev
BUD
$114B
| $6.82M | ﹤0.01% |
117,250
+3,160
| +3% | +$184K |
|
|
QSIG
1627
WisdomTree U.S. Short Term Corporate Bond Fund
QSIG
$44.2M
| $6.8M | ﹤0.01% |
142,917
+12,428
| +10% | +$592K |
|
1628
Manhattan Associates
MANH
$13.1B
| $6.8M | ﹤0.01% |
27,561
-11,076
| -29% | -$2.73M |
|
1629
First Trust Dividend Strength ETF
FTDS
$27.8M
| $6.79M | ﹤0.01% |
139,241
+2,857
| +2% | +$139K |
|
|
CHI
1630
Calamos Convertible Opportunities and Income Fund
CHI
$831M
| $6.79M | ﹤0.01% |
582,993
+12,513
| +2% | +$146K |
|
1631
Rithm Capital
RITM
$6.57B
| $6.78M | ﹤0.01% |
621,895
+215,267
| +53% | +$2.35M |
|
1632
FMC
FMC
$4.79B
| $6.78M | ﹤0.01% |
117,807
-1,461
| -1% | -$84.1K |
|
1633
Fidelity Low Duration Bond Factor ETF
FLDR
$1.01B
| $6.76M | ﹤0.01% |
135,461
+42,236
| +45% | +$2.11M |
|
1634
Vale
VALE
$45.5B
| $6.75M | ﹤0.01% |
604,653
+56,521
| +10% | +$631K |
|
1635
Medpace
MEDP
$13.8B
| $6.73M | ﹤0.01% |
16,337
+619
| +4% | +$255K |
|
1636
BlackRock Floating Rate Income Strategies Fund
FRA
$469M
| $6.72M | ﹤0.01% |
519,192
-121,825
| -19% | -$1.58M |
|
1637
SPDR SSGA Global Allocation ETF
GAL
$269M
| $6.69M | ﹤0.01% |
154,843
+6,613
| +4% | +$286K |
|
1638
Knife River
KNF
$4.42B
| $6.68M | ﹤0.01% |
95,240
+10,562
| +12% | +$741K |
|
1639
PIMCO Ultra Short Government Active ETF
BILZ
$899M
| $6.67M | ﹤0.01% |
65,999
-10,011
| -13% | -$1.01M |
|
1640
VanEck Short High Yield Muni ETF
SHYD
$353M
| $6.66M | ﹤0.01% |
297,900
+7,848
| +3% | +$176K |
|
1641
Illumina
ILMN
$14.6B
| $6.66M | ﹤0.01% |
63,790
-35,777
| -36% | -$3.73M |
|
1642
Fidelity Value Factor ETF
FVAL
$1.04B
| $6.65M | ﹤0.01% |
115,504
+898
| +0.8% | +$51.7K |
|
1643
Eaton Vance Tax-Advantaged Dividend Income Fund
EVT
$1.86B
| $6.64M | ﹤0.01% |
285,211
-927
| -0.3% | -$21.6K |
|
1644
Hormel Foods
HRL
$13.8B
| $6.64M | ﹤0.01% |
217,666
+43,994
| +25% | +$1.34M |
|
1645
Franklin FTSE India ETF
FLIN
$2.47B
| $6.63M | ﹤0.01% |
166,373
+35,893
| +28% | +$1.43M |
|
1646
Expedia Group
EXPE
$27.5B
| $6.61M | ﹤0.01% |
52,454
-15,130
| -22% | -$1.91M |
|
1647
FT Vest US Equity Buffer ETF January
FJAN
$1.13B
| $6.59M | ﹤0.01% |
151,779
-17,931
| -11% | -$778K |
|
1648
Innovator Laddered Allocation Power Buffer ETF
BUFF
$773M
| $6.57M | ﹤0.01% |
153,207
+106,649
| +229% | +$4.57M |
|
1649
Liberty Media Series C
FWONK
$24.9B
| $6.55M | ﹤0.01% |
91,113
+21,694
| +31% | +$1.56M |
|
1650
Invesco Biotechnology & Genome ETF
PBE
$224M
| $6.53M | ﹤0.01% |
100,759
+3,693
| +4% | +$239K |
|